SENSEX    73088.33       599.34    |    NIFTY    22147       151.15 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Stock Alert
Overall view of all the recent market developments which will help in your investment decisions
Granules India in spotlight after ANDA approval
20-Mar-18   07:52 Hrs IST

Granules India announced that the United States Food and Drug Administration (USFDA) has approved the abbreviated new drug application (ANDA) filed by the company for Metformin Extended Release (ER) Tablets 500 mg and 750 mg. The approved ANDA is the bioequivalent to the reference listed drug product (RLD), Glucophage XR tablets of Bristol Myers Squibb. Granules India intends to commercialise this product shortly. The announcement was made after market hours yesterday, 19 March 2018.

Nitesh Estates said that the discussions with investor for raising capital is in advanced stage and is expected to conclude around 30 April 2018. Nitesh Pune Mall, a subsidiary of Nitesh Estates had stated to the stock exchanges on 25 October 2017 regarding its discussions with certain investors for raising capital of over Rs 350 crore. The announcement was made after market hours yesterday, 19 March 2018.

IFCI said that the Supreme Court, in special leave petition filed by IFCI and ITC, has set aside the judgement of Bombay High Court and has upheld the sale of the hotel property of Blue Coast Hotels by IFCI. The announcement was made after market hours yesterday, 19 March 2018.

Tata Communications said it is working with Surbana Jurong, one of Asia's largest urban, industrial and infrastructure consulting firms, to equip its Internet of Things (IoT) enabled lifts and escalators with secure, scalable connectivity to Microsoft's Azure cloud platform. Tata Communications, Microsoft and Surbana Jurong will be discussing their collaboration in a keynote panel at IoT Asia on 21 March 2018. The announcement was made before market hours today, 20 March 2018.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 89.09 1.07
United Kingdom (GBP) 1.17 1.00 104.07 1.25
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.94 0.80 83.55 1.00
Market News << ALL News
  20-Apr-2024, (12:15 )  Jio Financial posts ..
  20-Apr-2024, (11:02 )  CRISIL upgrades rati..
  20-Apr-2024, (08:47 )  IREDA Q4 PAT climbs ..
  19-Apr-2024, (05:24 )  HDFC AMC Q4 PAT clim..
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)